Marc Galtier

585 total citations
19 papers, 470 citations indexed

About

Marc Galtier is a scholar working on Pharmacology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Marc Galtier has authored 19 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Epidemiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Marc Galtier's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pneumonia and Respiratory Infections (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Marc Galtier is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Pneumonia and Respiratory Infections (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Marc Galtier collaborates with scholars based in France and New Zealand. Marc Galtier's co-authors include Françoise Bressolle, Jean‐Jacques Eledjam, Jean‐Marie Kinowski, Jean E. de La Coussaye, Jacques Jourdan, Jeanne‐Marie Jacquet, D Donadio, David Fabre, P. Costa and Fátima Gonçalves and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Journal of Antimicrobial Chemotherapy and Clinical Pharmacokinetics.

In The Last Decade

Marc Galtier

19 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Galtier France 11 132 92 92 83 76 19 470
Martin Czejka Austria 15 245 1.9× 158 1.7× 80 0.9× 38 0.5× 37 0.5× 70 739
Dulal C. Chatterji United States 14 140 1.1× 131 1.4× 42 0.5× 49 0.6× 29 0.4× 31 563
R.K. Bhamra United Kingdom 11 74 0.6× 81 0.9× 67 0.7× 20 0.2× 104 1.4× 23 500
Jan A. Lieverst Netherlands 11 177 1.3× 114 1.2× 21 0.2× 29 0.3× 88 1.2× 12 448
Jerry I. Hirsch United States 18 92 0.7× 111 1.2× 27 0.3× 37 0.4× 46 0.6× 46 803
Polly E. Kintzel United States 14 247 1.9× 101 1.1× 56 0.6× 188 2.3× 44 0.6× 28 890
Jean‐Christophe Charniot France 11 121 0.9× 198 2.2× 19 0.2× 47 0.6× 44 0.6× 23 713
M. Guillaumont France 15 65 0.5× 84 0.9× 33 0.4× 62 0.7× 12 0.2× 26 620
G Fredj France 11 180 1.4× 84 0.9× 68 0.7× 48 0.6× 11 0.1× 40 483
P A Speth Netherlands 16 333 2.5× 280 3.0× 21 0.2× 48 0.6× 101 1.3× 24 861

Countries citing papers authored by Marc Galtier

Since Specialization
Citations

This map shows the geographic impact of Marc Galtier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Galtier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Galtier more than expected).

Fields of papers citing papers by Marc Galtier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Galtier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Galtier. The network helps show where Marc Galtier may publish in the future.

Co-authorship network of co-authors of Marc Galtier

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Galtier. A scholar is included among the top collaborators of Marc Galtier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Galtier. Marc Galtier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Galtier, Marc, et al.. (1995). Pharmacokinetic parameters of antipyrine in dog after hepatectomy. Biopharmaceutics & Drug Disposition. 16(8). 669–684. 6 indexed citations
2.
Sotto, Albert, Pascale Fabbro-Péray, Christian Carrière, et al.. (1995). An enzymatic method for assaying sulbactam in human serum: comparison with high performance liquid chromatography. Journal of Antimicrobial Chemotherapy. 35(3). 429–433. 3 indexed citations
3.
Paganin, Fabrice, Pascal Chanez, David Fabre, et al.. (1995). Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation. Biopharmaceutics & Drug Disposition. 16(5). 393–401. 13 indexed citations
4.
Kinowski, Jean‐Marie, Françoise Bressolle, Michel Rodier, et al.. (1995). A Limited Sampling Model with Bayesian Estimation to Determine Inulin Pharmacokinetics Using the Population Data Modelling Program P-PHARM. Clinical Drug Investigation. 9(5). 260–269. 11 indexed citations
5.
Bressolle, Françoise, Fátima Gonçalves, A Gouby, & Marc Galtier. (1994). Pefloxacin Clinical Pharmacokinetics. Clinical Pharmacokinetics. 27(6). 418–446. 24 indexed citations
6.
Bressolle, Françoise, et al.. (1994). Clinical Pharmacokinetics During Continuous Haemofiltration. Clinical Pharmacokinetics. 26(6). 457–471. 60 indexed citations
7.
Galtier, Marc, et al.. (1994). Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemotherapy and Pharmacology. 35(1). 1–9. 179 indexed citations
8.
Bologna, C, Juan‐Manuel Anaya, François Canovas, et al.. (1994). Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients. Arthritis & Rheumatism. 37(12). 1770–1773. 37 indexed citations
9.
Galtier, Marc, et al.. (1994). Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemotherapy and Pharmacology. 35(1). 1–9. 12 indexed citations
10.
Fabre, David, Françoise Bressolle, Roberto Goméni, et al.. (1993). Identification of Patients with Impaired Hepatic Drug Metabolism Using a Limited Sampling Procedure for Estimation of Phenazone (Antipyrine) Pharmacokinetic Parameters. Clinical Pharmacokinetics. 24(4). 333–343. 20 indexed citations
11.
Galtier, Marc, Françoise Bressolle, Jean-Emmanuel de La Coussaye, et al.. (1993). Multiple-Dose Pharmacokinetics of Pefloxacin in Patients with Hepatocellular Deficiency. Clinical Pharmacokinetics. 25(5). 415–423. 6 indexed citations
12.
Costa, P., et al.. (1993). Ceftriaxone pharmacokinetics in elderly subjects and penetration into epididymis. Biopharmaceutics & Drug Disposition. 14(2). 161–169. 9 indexed citations
13.
Costa, P., et al.. (1993). Multiple-Dose Pharmacokinetics of Moxisylyte after Oral Administration to Healthy Volunteers. Journal of Pharmaceutical Sciences. 82(9). 968–971. 6 indexed citations
14.
Bressolle, Françoise, et al.. (1993). Pharmacokinetics of Moxisylyte in Healthy Volunteers after intravenous and Intracavernous Administration. Journal of Pharmaceutical Sciences. 82(7). 729–733. 7 indexed citations
15.
Bressolle, Françoise, et al.. (1992). Penetration of pefloxacin into gynaecological tissues. Journal of Antimicrobial Chemotherapy. 29(5). 579–587. 4 indexed citations
16.
Costa, P., et al.. (1992). Disposition of roxithromycin in the epididymis after repeated oral administration. Journal of Antimicrobial Chemotherapy. 30(2). 197–201. 3 indexed citations
17.
Jacquet, Jeanne‐Marie, et al.. (1992). Doxorubicin and doxorubicinol plasma concentrations and excretion in parotid saliva. Cancer Chemotherapy and Pharmacology. 30(3). 215–218. 17 indexed citations
18.
Costa, P., et al.. (1992). Moxisylyte plasma kinetics in humans after intracavernous administration. Biopharmaceutics & Drug Disposition. 13(9). 671–679. 14 indexed citations
19.
Jacquet, Jeanne‐Marie, et al.. (1990). Doxorubicin and doxorubicinol: intra-and inter-individual variations of pharmacokinetic parameters. Cancer Chemotherapy and Pharmacology. 27(3). 219–225. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Czejka Breakdown of academic impact, for papers by Dulal C. Chatterji Breakdown of academic impact, for papers by R.K. Bhamra Breakdown of academic impact, for papers by Jan A. Lieverst Breakdown of academic impact, for papers by Jerry I. Hirsch Breakdown of academic impact, for papers by Polly E. Kintzel Breakdown of academic impact, for papers by Jean‐Christophe Charniot Breakdown of academic impact, for papers by M. Guillaumont Breakdown of academic impact, for papers by G Fredj Breakdown of academic impact, for papers by P A Speth
Rankless by CCL
2026